No earnings forecast score is currently available for Processa Pharmaceuticals Inc. The Biotechnology & Medical Research industry's average is 8.14. The average price target is 1.00, with a high of 1.00 and a low of 1.00.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Processa Pharmaceuticals Inc's price target?
Analysts forecast that Processa Pharmaceuticals Inc's price target is USD 1.00, with the highest forecast at USD 1.00 and the lowest forecast at USD 1.00.
How have Processa Pharmaceuticals IncPCSA's recent earnings per share performed?
The market expectation was USD -1.29, while Processa Pharmaceuticals IncPCSA's earnings per share (EPS) for the previous quarter was USD -1.49. EPS for the next quarter is expected at USD -1.00.